Preventive Mastectomy (cont.)
In this Article
- Preventive mastectomy facts*
- What is preventive mastectomy, and what types of procedures are used in preventive mastectomy?
- Why would a woman consider undergoing preventive mastectomy?
- How effective is preventive mastectomy in preventing or reducing the risk of breast cancer?
- What are the possible drawbacks of preventive mastectomy?
- What alternatives to surgery exist for preventing or reducing the risk of breast cancer?
- What is breast reconstruction?
- What type of follow-up care is needed after reconstructive surgery?
- Where can a person find more information about breast implants?
- Find a local Surgeon in your town
Where can a person find more information about breast implants?
The U.S. Food and Drug Administration (FDA) regulates the use of breast implants and can supply detailed information about these devices. To listen to recorded information or request free printed material on breast implants, consumers can contact the FDA Center for Devices and Radiological Health (CDRH) at:
U.S. Foods and Drug Administration
Center for Devices and Radiological Health
Office of Device Evaluation
10903 New Hampshire Avenue WO66-1676
Silver Spring, MD 20993-0002
Telephone: 1-888-INFO-FDA (1-888-463-6332), toll-free
(Call between 8:00 a.m. and 4:30 p.m., Eastern Standard Time, for either number.)
Medically reviewed by Mikio A Nihira, MD; American Board of Obstetrics & Gynecology
U.S. National Institutes of Health, National Cancer Institute
Singletary SE. Techniques in surgery: Therapeutic and prophylactic mastectomy. In: Harris JR, Lippman ME, Morrow M, Osborn CK, editors. Diseases of the Breast. 3rd ed. Philadelphia: Lippincott Williams and Wilkins, 2004.
Sherry RM. Cancer prevention: Role of surgery in cancer prevention. In: DeVita VT Jr., Hellman S, Rosenberg SA, editors. Cancer: Principles and Practice of Oncology. Vol. 1 and 2. 6th ed. Philadelphia: Lippincott Williams and Wilkins, 2001.
Dickson RB, Lippman ME. Cancer of the breast. In: DeVita VT Jr., Hellman S, Rosenberg SA, editors. Cancer: Principles and Practice of Oncology. Vol. 1 and 2. 6th ed. Philadelphia: Lippincott Williams and Wilkins, 2001.
Sakorafas GH. Women at high risk for breast cancer: Preventive strategies. The Mount Sinai Journal of Medicine 2002; 69(4):264-266.
Taucher S, Gnant M, Jakesz R. Preventive mastectomy in patients at breast cancer risk due to genetic alterations in the BRCA1 and BRCA2 gene. Langenbeck's Archives of Surgery 2003; 388(1):3-8.
Anderson BO. Prophylactic surgery to reduce breast cancer risk: A brief literature review. The Breast Journal 2001; 7(5):321-330.
Hartmann LC, Schaid DJ, Woods JE, et al. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. The New England Journal of Medicine 1999; 340(2):77-84.
Keefe KA, Meyskens FL Jr. Cancer prevention. In: Abeloff MD, Armitage JO, Lichter AS, Niederhuber JE, editors. Clinical Oncology. 2nd ed. London: Churchill Livingstone, 2000.
Levine DA, Gemignani ML. Prophylactic surgery in hereditary breast/ovarian cancer syndrome. Oncology 2003; 17(7):932-941.
Fisher B, Costantino JP, Wickerham DL, et al. Tamoxifen for the prevention of breast cancer: Current status of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. Journal of the National Cancer Institute 2005; 97(22):1652-1662.
Vogel VG, Costantino JP, Wickerham DL, et al. Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: The NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 Trial. Journal of the American Medical Association 2006; 295(23):2727-2741.
Monteiro M. Physical therapy implications following the TRAM procedure. Physical Therapy 1997; 77(7):765-770.
Viewers share their comments
Find support and advances in treatment.